1-3 of 3
Authors: Martin Hirsch
Sort by
Journal Article
Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211
Get access
Roy M. Gulick and others
The Journal of Infectious Diseases, Volume 196, Issue 2, 15 July 2007, Pages 304–312, https://doi.org/10.1086/518797
Published: 15 July 2007
Journal Article
A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy
Get access
Martin Hirsch and others
The Journal of Infectious Diseases, Volume 180, Issue 3, September 1999, Pages 659–665, https://doi.org/10.1086/314948
Published: 01 September 1999
Journal Article
A Randomized Trial of the Activity and Safety of Ro 24-7429 (Tat Antagonist) versus Nucleoside for Human Immunodeficiency Virus Infection
Get access
Richard H. Haubrich and others
The Journal of Infectious Diseases, Volume 172, Issue 5, November 1995, Pages 1246–1252, https://doi.org/10.1093/infdis/172.5.1246
Published: 01 November 1995
Advertisement
Advertisement